47.73.Z - Retail sale of pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
70.22.Z - Head office activities and management consultancy
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
82.99.Z - Other business support activities, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,3 | 2 | 1,1 | -45,4 |
EBITDA | 1,4 | 2,2 | 1,2 | -45 |
Short time liabilities | 1,1 | 0,6 | 1,5 | 137,6 |
Equity capital | 1,4 | 2,1 | 1,1 | -44,9 |
Operating profit (EBIT) | 1,3 | 2 | 1,1 | -45,4 |
Assets | 2,5 | 2,7 | 2,7 | -1,2 |
Net profit (loss) | 1,3 | 2 | 1,1 | -45,4 |
Cash | 0,4 | 0,3 | 0,2 | -43,4 |
Net income from sale | 9,4 | 15,4 | 10 | -35,5 |
Liabilities and provisions for liabilities | 1,1 | 0,6 | 1,5 | 137,6 |
Working assets | 2,1 | 2,5 | 2,5 | 1,8 |
Depreciation | 0 | 0,1 | 0,1 | -38,1 |
% | % | % | p.p. | |
Profitability of capital | 98,4 | 98,9 | 98 | -0,9 |
Equity capital to total assets | 55,7 | 76 | 42,4 | -33,6 |
Gross profit margin | 14,4 | 13,2 | 11,2 | -2 |
EBITDA Margin | 14,9 | 14 | 11,9 | -2,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 42 | 15 | 56 | 41 |
Current financial liquidity indicator | 1.9331191778182983 | 3.814838171005249 | 1.6340761184692383 | -2,2 |
Net dept to EBITDA | -0.26635152101516724 | -0.16184543073177338 | -0.16638389229774475 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane